The FDA is defending its increased use of non-binding guidance documents rather than legally-enforceable rulemakings, arguing ...

Johnson & Johnson has filed for two new pediatric indications as it looks to position its blockbuster immunotherapy Tremfya ...

Sanofi has made its single largest investment in China to date by pouring roughly €1 billion ($1.05 billion) into a new ...